(Total Views: 413)
Posted On: 04/28/2021 12:45:43 PM
Post# of 145254
Merck is also developing "ivermectin 2.0", so their recommendations to not use a widely-distributed expired patent, aren't above suspicion.
That's like asking Gilead if we should use remdesivir.
That's like asking Gilead if we should use remdesivir.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)